Aim Immunotech Inc.

This study is testing whether a drug called Ampligen can help people with severe chronic fatigue syndrome. Participants are adults aged 18-70 who have had the condition for at least a year and have significantly reduced quality of life. The study is open-label, meaning everyone k…

This study is testing if adding an investigational drug called Ampligen to standard cancer care helps people with locally advanced pancreatic cancer live longer without their cancer getting worse. It will compare the combination to standard care alone in about 90 people who have …